using monoclonal murine anti-actin antibodies suggesting the presence of non-muscle cell actin on mitogen transformed human lymphocytes. This monoclonal anti body repeatedly inhibited the stimulation of normal lymphocytes by mitogens (PHA, ConA, PWM) by >90% (as measured by the incorporation of 3~dThd) when added to the culture system in a final dilution of 1:12 to 1 :12,000 (p<0.0001), however a control myeloma cell 1 ine supernatant did not. The addition of purified rabbit thymus actin (RTA) to the culture system reversed this inhibition of lymphocyte pro1 i feration induced by the anti-actin antibody. However, it was not reversed by the addition of purified chicken muscle actin (CMA), nor bovine serum albumin (BSA We have recently shown that human neutrophils increase expression of C3bi as well as C3b receptors (R) in response to f-metleu-phe or other stimuli (J Clin Invest 74: 1566, '84). Using monoclonal antibodies and low cytometry, we found that ionophore A23187 and 1.2 mM Ca5+ increas d C3bR 330% and C3biR 650%. We therefore examined the role of Ca5+ in response to chemoattractants. Addition of ca2+ or EDTA to divalent cat n free media had no effect on C3bR expression while 1.2 mM Ca I-? -slightly enhanced and 5 mM EDTA markedly inhibited C3biR expression, sugge ting that the two receptors increase bydifferent mechanisms. Ng7+ EGTA effeclj? were identical to EDTA. TMB-8, which inhibits release of Ca from intracellular stores, completely blocked increased expression of both receptors at 200-250 uM. The calmodulin inhibitors chlorpromazine (50 uM) and trifluoperazine (10 uM) also blocked increased expression of both receptors while the inactive metabolite chlorpromazine sulfoxide had no effect. These results suggest that release of intracellular ca2+ is necessary and sufficient for maximal C3bR expression but that optimakexpression of C3biR also requires an in ux of extracellular Ca . gardless of the source of the Ca", formation of an active Ca5'-calmodulin complex appears to be necessary for increased complement receptor expression during neutrophil activation. 5 children with the Acquired Immunodeficiency Syndrome (AIDS) and 1 with AIDS related complex (ARC) were assessed with regard to specific antibody function. All patients were immunized with bacteriophage 0x174, a T cell dependent antigen. 5 children were immunized with tetanus toxoid, and 4 with pneumococcal vaccine. Serum immunoglobulins and mitogenic responses were measured in all children. Responses to bacteriophage 0x174 showed blunted primary responses and markedly decreased secondary responses, with absent class switch (IgM-IgG) in 5 of 6 patients. Antibody responses to tetanus toxoid and pneumococcal vaccine were diminished as well. 5 children had elevation of at least one immunoglobulin class. In vitro lymphocyte mitogenic responses, especially to staphylococcal cowan A and pokeweed, were diminished. Pediatric AIDS patients have significant abnormalities in humoral immunity. Both T and B cell dysfunction play a role. Three patients with AIDS and chronic diarrhea due to cryptos~oridia were treated with weeklv oral doses of bovine TF 1107 lkukocyte equivalents/kg) preparid from lymph nodes of cal;es immunized with cryptosporidia oocysts. All the patients demonstrated a resolution of their diarrhea and a cessation of oocyst excretion within 6 weeks of therapy. One patient relapsed upon cessation of TF therapy, while the other two remained cryptosporidia free for the duration of their observation. One of these individuals was subsequently started on weekly bovine TF therapy derived from calves immunized with pooled AIDS lymphoid cells and marker proteins diphtheria and tetanus toxoids (DT & 'IT) in complete Freund's adjuvant. Although there have been no qualitative changes in his T-cell phenotypes after 4 months of therapy, the patient has acquired in vitro proliferative responses to DT, TT and tuberculin. In addition, he has acquired delayed type skin responses to DT, TT and streptokinase -streptodornase. Concommitant with his immunologic reactivity, the patient has remained infection free during TF therapy.
EFFICACY OF BOVINE LEUKOCYTE DIALYSATES CONTAINING

TRANSFER FACTOR (TF) IN THE THERAPY OF THE ACQUIRED
Our experience with bovine TF immunotherapy suggests that (1) some degree of immunologic reconstitution is possible in patients with AIDS, and (2) cryptosporidiosis may respond to bovine TF administration. Thus, most infants with lethal primary immunodeficiency have the capacity to mature haploidentical stem cells to functioning T and B lymphocytes, and this process takes approximately 3 to 4 months.
DEVELOPMENT OF IMMUNITY IN SEVERE PRIMARY T CELL
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